Top Gainers & Losers: Tata Motors and Cipla gain as benchmarks slip; Adani Enterprises, Adani Ports tumble — Check target price

Gainers and Losers: Snapping its two-day gaining streak, the 30-share BSE Sensex ended 123.52 points or 0.20 per cent lower at 60,682.70.

Gainers and Losers:While Tata Motors became the top gainer on NSE followed by UPL, Cipla, Hero MotoCorp and HDFC Life Insurance, Pic- Reuters

Gainers and Losers: Equity benchmark Sensex declined 123 points on Friday due to selling pressure in metal and energy stocks amid a bearish trend in global equity markets. Rising crude prices and continued selling by foreign investors also weighed on market sentiment, traders said.

Snapping its two-day gaining streak, the 30-share BSE Sensex ended 123.52 points or 0.20 per cent lower at 60,682.70. During the session, the index touched a high of 60,774.14 and a low of 60,501.74. NSE Nifty slipped 36.95 points or 0.21 per cent to finish at 17,856.50.

Also Read: Layoffs in 2023: How to manage your finances amid job cuts

While Tata Motors became the top gainer on NSE followed by UPL, Cipla, Hero MotoCorp and HDFC Life Insurance.

On the flipside, Adani Enterprises, Adani Ports, HCL Tech, Hindalco, Tata Steel and Coal India were among the laggards.

Here are some blue-chip stocks that saw maximum buzz today:

Tata Motors

Tata Motors stock rallied by Rs 7.65 or 1.75 per cent at Rs 444.40 apiece on NSE.

Image source: NSE

Brokerage firm Julius Baer has given a ‘Buy’ call on Tata Motors’ stock and given a target price of Rs 525 apiece.

According to the report, Tata Motors is expected to see improved performance over the period in Jaguar Land Rover, driven by cyclical recovery, new launches/refreshes (including EVs), better mix, cost-cutting initiatives, and deleveraging.

The report further stated that the recent deal for PV EV has also created significant incremental value for Tata Motors.

Cipla Limited

Cipla Limited stock rose 1.13 per cent or Rs 11.50 at Rs 1,033 apiece on BSE.

Image source: NSE

Brokerage firm Axis Securities has maintained a ‘Buy’ call on Cipla stocks at a target price of Rs 1,300 per share.

Axis Securities expects Cipla to outpace industry growth in the US business. They also foresee continued momentum in recently launched products and a healthy pipeline of peptides, biosimilars and respiratory portfolio.

According to the report, India's business may outperform the Indian pharmaceutical market, led by sustained momentum in key chronic therapies.